Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
advisor, affirmative, Aid, alleviated, Amy, analyst, Andy, Arda, assumption, attack, attain, back, Bandy, Barton, BDO, Blackford, Blue, Bob, Brazil, Brister, burden, cardiometabolic, carryback, cast, ceded, CEO, collaboration, collaborative, collaborator, Dan, deep, description, detainer, disbursed, disbursement, discontent, dispersed, drastically, DVM, essential, essentially, evidencing, exacerbated, exploit, explore, faith, forgiven, formula, Gary, Gildred, Gladney, Governor, hereto, illegal, impression, incentivize, ineligible, internet, KPMG, landlord, Lori, lt, MacDonald, mailing, McDougal, Minocherhomjee, mortgage, multiplied, nationwide, nontechnical, outbreak, Ox, page, pandemic, Paycheck, pendency, penny, Ph, piggy, postpone, PPP, precautionary, printing, pro, promissory, rata, rebuild, recommence, redeeming, reestablish, reestablishing, rehire, reopen, reopened, repay, restrain, resumption, runway, SBA, scrutinizing, secondary, situation, sophisticated, sophistication, spread, stakeholder, Stankovich, surfaced, surviving, sweeping, thereon, timeline, Tom, uniform, unknown, unpaid, USA, Valley, vandenberg, waive, waived, wise, writ, Wuhan
Removed:
abdomen, absolute, absorbed, accompanied, accomplishment, adding, aesthetic, affix, aggressive, agree, agreeing, Allergan, altering, analytical, anatomy, ancillary, announce, announcing, Aspire, assemble, assistance, AstraZeneca, attracting, banding, BAROnova, billing, block, blocking, brain, breadth, caloric, cardiovascular, CDC, central, chemistry, chronic, competency, complement, complementary, configuration, conflict, consumed, contact, contracting, convened, convince, convincing, counsel, culture, currency, cycle, damaged, David, debarment, delivering, demographic, dental, desirable, desiring, disadvantage, disagreement, discounted, discouraged, dissatisfaction, documented, drop, dumping, earthquake, educated, efficiency, Eisai, emptying, enforcing, enjoy, enrolling, establishment, excessive, expanded, experimental, extremely, familiarity, fatty, favoring, feedback, feeding, fire, flooding, forecast, forensic, foundation, freely, gap, gelatin, grow, growing, half, hesitant, hunger, hurricane, impeded, implanted, improvement, inconclusive, inconvenient, incurrence, ineffective, ineffectively, influenced, initially, innovating, inoperable, instability, intake, integrate, interpret, introduced, inventive, invested, investigating, irreversible, jeopardized, justify, launching, learning, lessee, lifestyle, Moatazedi, modernize, musculoskeletal, necessitated, negotiation, neuroblocking, neuromodulation, Nutrition, nutritional, objective, obtainment, optimal, organic, outlet, outweigh, persist, persuaded, population, postoperative, preparing, prevalence, preventable, problem, produced, productivity, proficient, projected, proximity, purported, pursuit, questioned, radiopaqued, reaction, realize, recommend, reimburse, reject, rejection, relation, reluctance, render, rendering, repeatable, retained, role, satisfactory, scalable, sedentary, sensation, shifted, shortage, significance, site, skill, slower, sourced, specificity, sponsored, statistical, studied, suitable, supplementation, Surgeon, surgically, Survey, sustainable, syndrome, talented, target, targeted, terrorism, timeframe, trillion, tripled, trouble, tube, turnover, unmet, unsafe, unsatisfactory, vacate, varied, view, vitamin, widespread
Filing tables
Filing exhibits
Related press release
Associated RSLS transcripts
RSLS similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Obalon Therapeutics, Inc.
Carlsbad, California
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-213988, 333-218482, 333-224864, 333-232759, 333-235876, and 333-236062), Form S-3 (Nos. 333-221264 and 333-227160), and Form S-1 (Nos. 333-229142, 333-232276, and 333-236327) of Obalon Therapeutics, Inc. (“Company”) of our report dated March 12, 2021, relating to the consolidated financial statements, which appears in this Form 10-K.
/s/ BDO USA, LLP
Costa Mesa, California
March 12, 2021